Physician practices regarding anticoagulation and cardioversion of atrial fibrillation

Archives of Internal Medicine

Volumn 156, Issue 3, 1996, Pages 290-294

  Schlicht, John R ^a,c   Davis, Roy C ^a,d   Naqi, Khalid ^c   Cooper, William ^b,c   Rao, E Venkat ^c  

^a DUQUESNE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; WARFARIN;

ANTICOAGULATION; ARTICLE; CARDIOVERSION; GOOD CLINICAL PRACTICE; HEART ATRIUM FIBRILLATION; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RISK FACTOR; RISK MANAGEMENT; STROKE; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBROVASCULAR DISORDERS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES; WARFARIN;

EID: 0030024925     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.3.290     Document Type: Article

References (25)

1. Cook DJ, Guyatt GH, Laupacis A, Sackett DL Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1992;102 (suppl4):305S-311S.
2. American College of Chest Physicians. Third American College of Chest Physicians' Consensus Conference on Antithrombotic Therapy Chest. 1992;102 (suppl 4):303S-549S.
3. American College of Chest Physicians and National Heart, Lung, and Blood Institute National Conference on Antithrombotic Therapy. Chest. 1986;89 (suppl 1):1S-106S.
4. American College of Chest Physicians. Second American College of Chest Physicians' Consensus Conference on Antithrombotic Therapy. Chest. 1989;95 (suppl 1):1S-169S.
5. Kannel WB, Abbott RO, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation. N Engl J Med. 1982;306:1018-1022.
6. Flaker GC, Wright GC, Alpert MA Atrial fibrillation: new ideas on an old arrhythmia. Cardiovasc Rev Rep. 1990;11:39-45.
7. Fisher CM Reducing risks of cerebral embolism. Geriatrics 1979;34:59-66
8. Bjerkelund CJ, Orning OM. The efficacy of anticoagulant therapy in preventing embolism related to DC electrical cardioversion of atrial fibrillation. Am J Cardiol. 1969;23:208-216.
9. Goldman MJ The management of chronic atrial fibrillation: indications and method of conversion to sinus rhythm. Prog Cardiovasc Dis. 1960,2:465-479.
10. Resnekov L, McDonald L Complications in 220 patients with cardiac dysrhythmias treated by phased DC shock and indications for electroversion. Br Heart J. 1967;29:926-936.
11. McCarthy C, Varghese PJ, Baritt DW. Prognosis of atrial arrhythmias treated by electrical countershock therapy: a three-year follow-up Br Heart J. 1969, 31.496-500
12. Lown B. Electrical reversion of cardiac arrhythmias Br Heart J. 1967 29:469-489
13. Laupacis A, Albers G, Dunn M, Feinberg W. Antithrombotic therapy in atrial fibrillation. Chest. 1992;102(suppl 4).426S-433S.
14. Manning WJ, Leeman DE, Gotch PJ, Come PC. Pulsed doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol. 1989;13:617-623.
15. O'Neill PG, Puteo PR, Bolli R, Rokey R. Return of atrial mechanical function following electrical cardioversion of atrial dysrhythmias. Am Heart J. 1990; 120:353-359
16. Hirsh J, Dalen JE, Deykin D, Poller L. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest. 1992; 102(suppl 4):337S-351S.
17. Hirsh J, Dalen JE, Deykin D, Poller L. Oral anticoagulants, mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1992;102 (suppl 4):312S-326S.
18. Hyers TM, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest. 1992;102(suppl 4):408S-425S.
19. Schweizer P, Bardos P, Erbel R, et al. Detection of left atrial thrombi by echocardiography Br Heart J. 1981;45:148-156.
20. Bansat RC, Heywood JT, Applegate PM, Jutzy KR. Detection of left atrial thrombi by two-dimensional echocardiography and surgical correlation in 148 patients with mitral valve disease. Am J Cardiol. 1989;64:243-246.
21. Sherman DG, Dyken ML, Fisher M, Gent M, Harrison M, Hart RG. Antithrombotic therapy for cerebrovascular disorders. Chest. 1992,102(suppl 4):529S-537S.
22. Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. J Am Coll Cardiol. 1995;25:1354-1361.
23. Black IW, Fatkin D, Sagar KB, et al. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation: a multicenter study. Circulation. 1994;23:307-316
24. Grimm RA, Stewart WJ, Black IW, Thomas JD, Klein AL. Should all patients undergo transesophageal echocardiography before cardioversion of atrial fibrillation? J Am Coll Cardiol. 1994;23:533-541.
25. Daniel WG, Mugge A. Transesophageal echocardiography N Engl J Med. 1995; 332:1268-1279.